'In the flu season, we see that people's symptoms are worse. Their immunity is weakening. If coughs used to last two weeks, now we see that people have coughs that last for a month or six weeks' - Ermek Ismailov, a Bishkek-based physician
The health impacts are less amusing.
Since then, urban populations have grown, with the number of cars increasing beyond the capacity of metropoles that grew in a time when only the more privileged had a vehicle to their name. Last year, RFE/RL's Kazakh Service reported that of 30,000 private houses in the city, only 5,000 were connected to a gas line.take to the roads each year.While at least two countries in the region -- Kazakhstan and Uzbekistan -- are ramping up investment in renewable energy, there are doubts about how quickly wind and solar projects can be scaled up to replace fossil fuel-based energy sources such as coal and natural gas in the region's growing cities.
This summer, QazaqGaz Director Sanzhar Zharkeshov said the status quo would need to change if a popular desire to convert a key Almaty power station from coal to natural gas was to be realized. Uzbekistan and Kazakhstan have stated their intent to build nuclear power plants to ease the pressure on overworked grids and reduce reliance on coal-burning power plants.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Leaders, activists and water firms invited to Shrewsbury river pollution meetingLeaders, activists and water firm bosses have been invited to discuss river pollution at a meeting in Shrewsbury in the new year.
Lire la suite »
New 50ft phone mast knocked back over impact on £300m Blackpool CentralThe structure would negatively impact views of Blackpool Tower and the looming £300m Blackpool Central development
Lire la suite »
Central banks should beware mistaking wage rises for an inflation problem\n\t\t\tLet our global subject matter experts broaden your perspective with timely insights and opinions you\n\t\t\tcan’t find anywhere else.\n\t\t
Lire la suite »
Ecstatic scenes in Buenos Aires as Argentina soars to World Cup victoryA sea of blue-and-white fans crowded into central Buenos Aires waving flags and blaring horns as Argentina soared to victory in the World Cup final.
Lire la suite »
Cold that 'feels like Covid' sweeps UK - how to get rid of 'worst' lurgyA pharmacist shares the best home remedies to treat a nasty cough without visiting a doctor.
Lire la suite »
Gabapentinoids for Pain: A Review of Published Comparative Effectiveness Trials and Data Submitted to the FDA for Approval - DrugsUse of the gabapentinoids for pain continues to increase. In 2018, the US Food and Drug Administration (FDA) strengthened the warnings for both gabapentin and pregabalin to emphasize the central nervous system side effects and the risk of respiratory depression, especially when combined with other centrally acting drugs. We reviewed the published comparative effectiveness literature for gabapentinoids for pain as well as all trials (published and unpublished) used by the FDA for the approval of the five pain indications for these agents (one for gabapentin, four for pregabalin). Among the findings of interest are the fact that the FDA rejected the application for gabapentin for diabetic peripheral neuropathy based on the risk versus benefit profile of that drug in the clinical trials that were submitted by the manufacturer. Additionally, both the comparative effectiveness trials as well as the studies used by the FDA tend to be short in duration and show only modest pain benefits for the gabapentinoids. The placebo response in these trials was frequently one-third to one-half as great as the pain benefit demonstrated by the gabapentinoid. Based on the available clinical trial evidence, we feel prescribers should be cautious when using gabapentinoids for pain, particularly when using these agents for a prolonged period or when combined with other, centrally acting agents.
Lire la suite »